; and (8) drugs purchased under the 340B program account for a small proportion of overall drug spending and the discounts described in paragraph (2) provided through the 340B program are not funded by taxpayers. 3. Codifying definition of patient under 340B program Section 340B(b) of the Public Health Service Act ( 42 U.S.C. 256b ) is amended by adding at the end the following new paragraph: (3) Patient (A) In general For purposes of carrying out this section, the term patient shall have the definition given to such term on pages 55156 through 55158 of title 61 of the Federal Register published on October 24, 1996. (B) Clarification For purposes of this section, the Secretary shall not implement the definition under subparagraph (A) more narrowly than the definition specified in subparagraph (A), including by limiting the application of the definition to particular individuals based on their insurance status. . 4. Non-discrimination with respect to covered entities Section 340B of the Public Health Service Act ( 42 U.S.C. 256b ) is amended by adding at the end the following new subsection: (f) Non-Discrimination with respect to covered entities (1) Terms of agreement Subject to paragraph (3), no entity that reimburses a covered entity or its contract pharmacy for drugs that are subject to an agreement under this section may discriminate against such covered entity with respect to the terms of such reimbursement, including terms relating to the level and amount of reimbursement, on the basis that the covered entity participates in the program under this section. (2) Patient’s choice With respect to a patient eligible to receive drugs that are subject to an agreement under this section from a covered entity or its contract pharmacy, no entity that makes payment for such drugs shall discriminate against the covered entity or its contract pharmacy in a manner that prevents or interferes with the patient’s choice to receive such drugs from the covered entity or contract pharmacy. (3) Exception Paragraph (1) shall not